跳至主要内容
临床试验/EUCTR2015-000549-21-GB
EUCTR2015-000549-21-GB进行中(未招募)1 期

MAGnetic versus STAndard technique for sentinel node biopsy in breast cancer compared in a Randomised controlled trial - MAGSTAR Trial

King's College London0 个研究点目标入组 99,999 人开始时间: 2015年3月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
99,999

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1) Male and female patients with breast cancer over the age of 18yrs
  • 2) Patients who are clinically and radiologically node negative or patients who underwent a negative core biopsy or cytology of an ipsilateral axillary lymph node
  • 3) Patients scheduled for SLNB
  • 4) Patients who provided informed consent to participate in this study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 524
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 400

排除标准

  • 1) Patients who are pregnant at the time of diagnosis
  • 2) Known intolerance / hypersensitivity to methylene blue dye
  • 3) Known intolerance / hypersensitivity to iron or dextran compounds
  • 4) Patients who decline to receive radioisotope or blue dye for SLNB
  • 5) Patients with a pacemaker or other implantable devices in the chest wall (Patients with implanted devices elsewhere in the body are allowed)
  • 6) Patients undergoing SLNB prior to primary chemotherapy

研究者

相似试验